GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Bloomage BioTechnology Corp Ltd (SHSE:688363) » Definitions » EV-to-EBITDA

Bloomage BioTechnology (SHSE:688363) EV-to-EBITDA : 55.86 (As of Dec. 13, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Bloomage BioTechnology EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Bloomage BioTechnology's enterprise value is ¥29,889 Mil. Bloomage BioTechnology's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was ¥535 Mil. Therefore, Bloomage BioTechnology's EV-to-EBITDA for today is 55.86.

The historical rank and industry rank for Bloomage BioTechnology's EV-to-EBITDA or its related term are showing as below:

SHSE:688363' s EV-to-EBITDA Range Over the Past 10 Years
Min: 31.28   Med: 56.61   Max: 157.38
Current: 55.86

During the past 8 years, the highest EV-to-EBITDA of Bloomage BioTechnology was 157.38. The lowest was 31.28. And the median was 56.61.

SHSE:688363's EV-to-EBITDA is ranked worse than
88.29% of 1272 companies
in the Chemicals industry
Industry Median: 14.93 vs SHSE:688363: 55.86

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-12-13), Bloomage BioTechnology's stock price is ¥61.66. Bloomage BioTechnology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥0.910. Therefore, Bloomage BioTechnology's PE Ratio (TTM) for today is 67.76.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Bloomage BioTechnology EV-to-EBITDA Historical Data

The historical data trend for Bloomage BioTechnology's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bloomage BioTechnology EV-to-EBITDA Chart

Bloomage BioTechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial 49.57 82.33 68.39 46.46 31.91

Bloomage BioTechnology Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.41 31.91 34.19 43.89 63.08

Competitive Comparison of Bloomage BioTechnology's EV-to-EBITDA

For the Specialty Chemicals subindustry, Bloomage BioTechnology's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bloomage BioTechnology's EV-to-EBITDA Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Bloomage BioTechnology's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Bloomage BioTechnology's EV-to-EBITDA falls into.



Bloomage BioTechnology EV-to-EBITDA Calculation

Bloomage BioTechnology's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=29889.450/535.121
=55.86

Bloomage BioTechnology's current Enterprise Value is ¥29,889 Mil.
Bloomage BioTechnology's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥535 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bloomage BioTechnology  (SHSE:688363) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Bloomage BioTechnology's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=61.66/0.910
=67.76

Bloomage BioTechnology's share price for today is ¥61.66.
Bloomage BioTechnology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.910.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Bloomage BioTechnology EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Bloomage BioTechnology's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Bloomage BioTechnology Business Description

Traded in Other Exchanges
N/A
Address
No. 678 Tianchen Avenue, High-Tech Development Zone, Shandong Province, Jinan City, CHN
Bloomage BioTechnology Corp Ltd manufactures and sells a variety of chemicals and chemical-based products, typically made from hyaluronic acid sodium, or HA. The firm organizes itself into two segments based on product type. The HA raw materials segment, which generates the majority of revenue, sells HA and HA derivatives produced using bio-fermentation technology. The HA raw materials segment products are classified into three grades of HA: medicine grade, cosmetic grade, and food grade. The HA end products segment sells medical skin care products, bone products for intra-articular injection, and medical beauty devices. The majority of revenue comes from China.
Executives
Zhao Yi Core technical personnel
Luan Yi Hong Core technical personnel
Shi Yan Li Core technical personnel
Liu Jian Jian Core technical personnel
Wang Yu Ling Core technical personnel
Zhou Wei Core technical personnel
Huang Si Ling Core technical personnel
Han Hong Ling Core technical personnel
Lu Zhen Core technical personnel

Bloomage BioTechnology Headlines

No Headlines